Asking patients using pharmacy services what they need

by Stephanie West, RPS Regional Liaison Pharmacist

In our previous blog, Nicky Gray spoke about the ‘strength and authenticity’ of relationships between stakeholders as central to successful integrated working. The same holds true when engaging the populations we serve. Promoting a positive patient experience of health and social care services, through providing integrated out-of-hospital care for patients, is a central aim for PCNs.

Community pharmacy has firm foundations to build upon. The National Healthwatch Report 2016 found that:

  • Three quarters of people say they would go to a pharmacist, rather than a GP, to get medication for a minor illness.
  • Over half would go to a pharmacist to seek advice for a specific minor illness or injury.
  • A third of people would consider using a pharmacy instead of visiting a GP for general medical advice.’

Community pharmacy was also the healthcare service of choice for ‘traditionally harder to engage groups.’ Significantly, the report found that participants ‘trusted the pharmacist’.

Asking patients

One thing that strikes me is – how are patients being consulted and educated about the increasing clinical services delivered by pharmacists? How is the patient voice being captured?

GP Practices have engaged with patients through Patient Participation Groups for many years, to make sure ‘that their practice puts the patient, and improving health, at the heart of everything it does’ These could be a useful forum to capture patient views on new ways of accessing care from the wider PCN team. If you are part of a group focussing on the role of pharmacists in the practice, please get in touch.

Community pharmacists have to conduct an annual patient survey. This focuses on traditional services and advice-giving and could be developed to raise awareness of different clinical services. 

The Berwick Review called for the NHS to ‘Engage, empower, and hear patients and carers at all times’. NHS Trusts have patient and public engagement strategies, recognising the importance of capturing patient views. There are opportunities to do this, many trusts will have patient representation on their Medicines Safety Committee, but can we engage them more widely as strategies for pharmacy and medicines optimisation are developed across Integrated Care Systems?

Shared decision-making

Liberating the NHS: No decision about me without me  focussed on shared-decision making. How are pharmacists ensuring that patients are fully involved in decisions about their own care and treatment? How is pharmacy linked with local communities, groups and networks? NICE Guidance identifies Shared decision-making as ‘an essential part of evidence-based medicine’ and the NHS Patient Safety Strategy 2019 commits to: ‘Commission shared decision-making (SDM) training for clinical pharmacists moving into PCNs, to work with patients with atrial fibrillation (AF) on anticoagulants’.

Get in touch

Our new System Leadership Resource section on ‘Culture Change’ includes a focus on meaningful engagement with local people. If you have a case study showing how you have improved health outcomes or developed a service through patient engagement, shared-decision making and/or co-production we would like to share your insights so please do contact us.


 


.

Biosimilar adalimumab is a test of shared decision making in the NHS

Co-written by the National Rheumatoid Arthritis Society, National Ankylosing Spondylitis Society, RNIB, Birdshot Uveitis Society, Psoriasis Association and Crohn’s & Colitis UK

The entry of new biosimilars and the creation of an NHS ‘local market of treatment options’ will see significant numbers of patients switched from the originator product, Humira, to one of four biosimilar alternatives this year.

Adalimumab is one of several biological drugs used in the treatment of autoimmune inflammatory diseases, including rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, non-infectious posterior uveitis, Crohn’s and colitis.

While some patients will take this in their stride, for others the change will be met with feelings of apprehension. Read more Biosimilar adalimumab is a test of shared decision making in the NHS

Polypharmacy – what is it and why is it important?

By Clare Howard, FFRPS FRPharmS, lead author of the RPS guidance Polypharmacy: getting our medicines right

What is polypharmacy?
We know that medicines have an enormous, positive impact on the lives of millions of people. But as more of us live longer, with multiple long-term conditions, we take more and more medicines. Taking many different medicines at once can become either a practical challenge or increase the likelihood of harm, or both.

Problems with polypharmacy happen when: 
• Medicines are prescribed that are no longer clinically indicated, appropriate or optimised for that person
• The harm of a particular medicine outweighs the benefit
• The combination of medicines being taken has the potential to, or is actually causing harm to the person
• Where the practicalities of using the medicines have become unmanageable or are causing harm or distress.  Read more Polypharmacy – what is it and why is it important?

Improving mental and physical health – parkrun

By Chrissie Wellington, Global Head of Health and Wellbeing, parkrun

We all know that exercise is one way to improve physical and mental health, but it can be very hard to get started and motivate yourself to continue exercising.

I work for a brilliant organisation called parkrun which provides a fantastic way for anyone to improve their physical and mental health in a fun and supportive environment.

As a non-profit organisation, parkrun organises free 5k runs which take place every Saturday at 9am (9:30am in Scotland and Northern Ireland). There are currently over 770 parkrun events across the UK with approximately 140,000 weekly participants supported by around 14,000 volunteers.  Read more Improving mental and physical health – parkrun

Getting started as a clinical pharmacist

rachel_hall-150by Rachel Hall, clinical pharmacist

I’m a clinical pharmacist and partner at the Old School Surgery in Bristol, an inner city practice with more than 15,000 patients.

Getting started as a practice pharmacist
During my training, I worked for one day a week at the practice, specialising in treating patients with type 2 diabetes. This work convinced the partners they needed a permanent clinical pharmacist, rather than taking on a salaried GP. Read more Getting started as a clinical pharmacist

Why pharmacists need to take the lead in listening

Alan_Willson_web2By Dr Alan Willson, a director of 1000 Lives Plus

There is a growing sense that NHS organisations need to become more skilled at listening to patients, families and citizens, to understand what people really want and need from their healthcare services. Read more Why pharmacists need to take the lead in listening

Fake medicines – a real danger

By Neal Patel, Head of Corporate Communications

As part of our commitment to patient safety, we’re proud to be involved in the Real Danger campaign, which aims to raise awareness of the dangers of buying prescription medicine online without a consultation with a heath professional or proper authority. We took part in important research that resulted in some alarming statistics:

Read more Fake medicines – a real danger